Price range: £84.35 through £138.00
Semax is a Semax peptide derived from the ACTH(4–10) fragment and engineered for enhanced stability in neurological research environments. Scientists use this heptapeptide to study cognitive regulation, neurotrophic signaling, and CNS-mediated adaptive responses. Because its structure interacts with central neurochemical pathways without corticosteroid effects, the Semax peptide supports focused investigations into neuronal communication and gene-expression influence.
Researchers value the Semax peptide for its role in experiments that explore memory processes, synaptic plasticity, and stress-response modulation. It allows laboratories to examine how small peptide analogues may affect BDNF-related signaling, neurotransmitter balance, and functional neuroadaptive behavior. Additionally, Semax enables direct comparisons with other ACTH-derived peptides to assess structural contributions to receptor interaction and intracellular response.
Teams often buy the Semax peptide for controlled studies involving:
Analysing cognitive-pathway signaling in vitro or ex vivo
Mapping neurotrophic influences on gene expression and synaptic function
Exploring CNS adaptation to stress or behavioral stimuli
Differentiating activity among ACTH-fragment analogues
Because Semax shows well-defined activity under laboratory testing, it supports reproducible outcomes across replicates and assay formats. Its properties make it suitable for mechanistic neurobiology research where consistency, timing, and targeted peptide interaction are essential.
Our Semax peptide is produced as a high-purity laboratory reagent for qualified research environments only. It is not approved for clinical, therapeutic, diagnostic, or veterinary use. All handling must follow relevant institutional and regulatory safety guidelines.
For research use only. Not for human consumption.
Discount Applied Successfully!
Your savings have been added to the cart.
